BPCL Q3: Brokerages bullish on long-term growth outlook, await relief in upcoming Budget
CLSA upgraded the stock to 'hold', citing recent corrections, despite inventory losses and weaker refining margins.
阿思達克財經網1h
Trump Says He Knows Interest Rates Much Better Than Powell
US President Donald Trump questioned Federal Reserve Chairman Jerome Powell's decisions on interest rates, saying that he plans to talk to Powell at an appropriate time, foreign news reports said.
CLSA lowers Dr. Reddy's shares price target, citing lack of near-term growth triggers
CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...
CLSA cuts Dr. Reddy's stock rating to Underperform
CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...
CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth
The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...
The Financial Express21h
HUL drops to 8-month low on margin concerns
Taking a more bearish stance, CLSA has downgraded HUL to an Underperform rating. The brokerage firm also has slashed its ...
The Edge Singapore21h
Re-union of the Snake
There is mild anticipation that as the Snake year slithers in, the local IPO markets will open up, and the STI will hit a new ...
Healthcare stocks rally over 2% as CLSA upgrades Dr Lal Pathlabs and Aurobindo; DRL drops on downgrade
Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...